Article
PET imaging of focused-ultrasound enhanced delivery of AAVs into the murine brain
1 Jan 2023
Abstract excerpt
Rationale: Despite recent advances in the use of adeno-associated viruses (AAVs) as potential vehicles for genetic intervention of central and peripheral nervous system-associated disorders, gene therapy for the treatment of neuropathology in adults has not been approved to date. The currently FDA-approved AAV-vector based gene therapies rely on naturally occurring serotypes, such as AAV2 or AAV9, which display...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
